HR
DVAX

Howe & Rusling’s Dynavax Technologies DVAX Stock Holding History

Howe & Rusling’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-225
Closed -$2K – 527
2022
Q3 		$2K Sell
225
-78
-26% -$1.02K ﹤0.01% 854
2022
Q2 		$4K Hold
303
– – ﹤0.01% 690
2022
Q1 		$3K Hold
303
– – ﹤0.01% 771
2021
Q4 		$4K Hold
303
– – ﹤0.01% 715
2021
Q3 		$6K Hold
303
– – ﹤0.01% 586
2021
Q2 		$3K Hold
303
– – ﹤0.01% 730
2021
Q1 		$3K Sell
303
-190
-39% -$1.57K ﹤0.01% 738
2020
Q4 		$2K Hold
493
– – ﹤0.01% 788
2020
Q3 		$2K Buy
493
+333
+208% +$2.38K ﹤0.01% 699
2020
Q2 		$1K Buy
+160
New +$809 ﹤0.01% 732

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Howe & Rusling's DVAX Position: Q4 2022 in Review

Howe & Rusling sold out of Dynavax Technologies (DVAX) in Q4 2022, closing a stake of 225 shares — an estimated $2K sold.

Howe & Rusling first reported a position in DVAX in Q2 2020 and held it in 10 quarters. The position peaked at $6K in Q3 2021. 230 funds tracked by Wall St. Rank hold DVAX as of Q4 2022.

  • Howe & Rusling reported no remaining Dynavax Technologies position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 225 Dynavax Technologies shares in Q4 2022, an estimated $2K.
  • Howe & Rusling first reported a position in Dynavax Technologies in Q2 2020 and held it in 10 quarters.
  • Howe & Rusling's Dynavax Technologies position peaked at $6K in Q3 2021.
  • 230 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.